SCHEMBL6152983

SCHEMBL6152983

Cc1cc(N2CCN(CCO)CCN(CCO)CC2)ccc1N

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.70
RAD52 P43351 2/20 0.70
MAPT P10636 6/20 0.46
MAPK1 P28482 3/20 0.46
KDM4E B2RXH2 2/20 0.46
HTT P42858 1/20 0.46
RECQL P46063 1/20 0.46
PTK2B Q14289 1/20 0.46
KCNH2 Q12809 2/20 0.43
DRD2 P14416 2/20 0.42
GFER P55789 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HPGD P15428 2/20 0.41
ALDH1A1 P00352 2/20 0.41
TP53 P04637 2/20 0.41
LMNA P02545 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
THRB P10828 1/20 0.40
BCL2A1 Q16548 1/20 0.40
DRD4 P21917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15803912 1.00 GAA (0.70) GAARAD52MAPTMAPK1KDM4E
SCHEMBL6151852 1.00 GAA (0.70) GAARAD52MAPTMAPK1KDM4E
SCHEMBL5206554 0.94 GAA (0.63) GAARAD52MAPTMAPK1KDM4E
SCHEMBL6151838 0.91 GAA (0.67) GAARAD52MAPTMAPK1KDM4E
SCHEMBL6151541 0.86 GAA (0.72) GAARAD52MAPTMAPK1KDM4E
SCHEMBL3538619 0.86 GAA (0.50) GAARAD52MAPTMAPK1KDM4E
SCHEMBL5203995 0.85 GAA (0.56) GAARAD52MAPTMAPK1KDM4E
SCHEMBL5202443 0.85 GAA (0.56) GAARAD52MAPTMAPK1KDM4E
SCHEMBL22652063 0.85 GAA (0.70) GAARAD52MAPTMAPK1KDM4E
SCHEMBL5203157 0.84 GAA (0.54) GAARAD52MAPTMAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050120494-A1 Triazacyclononane derivatives substituted on at least one of the nitrogen atoms with a substituted or unsubstituted 4'-aminophenyl group, for dyeing keratin fibres L'OREAL S.A. (FR) 2005-06-09 US claimed
EP-1518860-A1 Triazacyclononane derivatives substituted on at least one of the nitrogene atoms by a 4-aminophenyle group for dyeing keratinic fibres L'OREAL (FR) 2005-03-30 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050120494-A1 Triazacyclononane derivatives substituted on at least one of the nitrogen atoms with a substituted or unsubstituted 4'-aminophenyl group, for dyeing keratin fibres KRT18, TUBB6, TUBB1 GAA 4694/4885RAD52 553/4885MAPT 945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.